HR (Paroven, Venoruton; 0-(β-hydroxyethyl)-rutosides) in Venous Hypertensive Microangiopathy: A Prospective, Placebo-Controlled, Randomized Trial
Titel:
HR (Paroven, Venoruton; 0-(β-hydroxyethyl)-rutosides) in Venous Hypertensive Microangiopathy: A Prospective, Placebo-Controlled, Randomized Trial
Auteur:
Incandela, L. Belcaro, G. Renton, S. DeSanctis, M. T. Cesarone, M. R. Bavera, P. Ippolito, E. Bucci, M. Griffin, M. Geroulakos, G. Dugall, M. Golden, G. Acerbi, G.
Verschenen in:
Journal of cardiovascular pharmacology and therapeutics